Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy

As described in the publication, each treatment dose consisted of 1 ml of exosome solution, containing a defined range of exosome particle numbers, mixed with 5 ml of saline. The solution was ...
Nasdaq

SBIO Was ALPS’ Top Performing ETF in August

The ALPS Medical Breakthroughs ETF (SBIO) was ALPS' top-performing ETF in August, propelled by positive earnings and M&A announcements in the portfolio. SBIO increased 8.65% on a total return basis ...
Houston Chronicle

Should You Invest in the ALPS Medical Breakthroughs ETF (SBIO)?

If you're interested in broad exposure to the Healthcare - Broad segment of the equity market, look no further than the ALPS Medical Breakthroughs ETF (SBIO), a passively managed exchange traded fund ...
Seeking Alpha

SEALSQ Enters the Healthcare Industry Through IC’Alps, Delivering Custom Integrated Chip Solutions and Post-Quantum Protection for Next-Generation Medical Devices

SEALSQ Corp (LAES), ("SEALSQ" or "Company"), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced its ...
AOL

SBIO Was ALPS’ Top Performing ETF in August

This article was originally published on ETFTrends.com. The ALPS Medical Breakthroughs ETF (SBIO) was ALPS' top-performing ETF in August, propelled by positive earnings and M&A announcements in the ...